Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class II · Moderate risk Terminated Initiated Jan 10, 2020 (7 years ago)

Estriol USP Micronized a) 100 gm NDC 62991-2159-04

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Subpotent

Cause type: Wrong potency / content

Sub- or super-potent product, or a failed content-uniformity / assay test. You may receive too little or too much active ingredient - a direct dosing risk. All wrong potency / content recalls.

What was recalled

Estriol USP Micronized a) 100 gm NDC 62991-2159-04; b) 1 gm NDC 62991-2159-01; c) 1 kg NDC 62991-2159-06; d) 25 gm NDC 62991-2159-03; e) 500 gm NDC 62991-2159-05; f) 5 gm NDC 62991-2159-02, Rx Only Repackaged by: Letco Medical, LLC. Decatur, AL 35601

Affected NDCs 62991-2159-01 62991-2159-02 62991-2159-03 62991-2159-04 62991-2159-05 62991-2159-06

Compare with the code on your package — it is the most precise check available.

Drug: Estriol

Product details

From the FDA NDC directory, for the product code this recall names. Compare with the label on your package.

ProductStrengthForm & routeLabelerType
Estriol Micronized
NDC 62991-2159
ESTRIOL 1 g/g Powder Letco Medical, LLC BULK INGREDIENT
Recalling firm
Letco Medical LLC
NDC code
62991-2159-04
Origin
AL, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0780-2020 · FDA notice

Check, then ask. Class II means harm is possible but usually temporary or reversible. Find the lot number on your package; if it matches, ask your pharmacist about a replacement. Do not simply stop a prescribed medication on your own - the gap can be riskier than the recall. This recall is now terminated, which means the firm has finished removing the affected product; anything on pharmacy shelves today should be unaffected.

Other Estriol recalls

See all
Class II · Moderate risk

Estriol 1mg/gm

Lack of Processing Controls: Insanitary conditions observed during recent FDA Inspection

Terminated cGMP deviation Wedgewood Village Pharmacy, LLC D-1186-2022
Class II · Moderate risk

Estriol 1mg/gm

Lack of Processing Controls: Insanitary conditions observed during recent FDA Inspection

Terminated cGMP deviation Wedgewood Village Pharmacy, LLC D-1185-2022
Class II · Moderate risk

Estriol 8 mg Capsule

Lack of Processing Controls (lack of assurance of conformity to specifications).

Terminated cGMP deviation MasterPharm LLC D-1421-2020
Class II · Moderate risk

Estriol 6 mg Capsule

Lack of Processing Controls (lack of assurance of conformity to specifications).

Terminated cGMP deviation MasterPharm LLC D-1420-2020

Other recalls by Letco Medical LLC

All 2020 recalls
Class III · Low risk

Espumil

Labeling: Not Elsewhere Classified

Ongoing Labeling / mix-up Letco Medical LLC D-0138-2026